跳至主要内容
临床试验/CTRI/2015/09/006171
CTRI/2015/09/006171尚未招募2 期

11 beta HSD-1 gene polymorphism in patients with type 2 diabetes, metabolic syndrome and PCOS- Effect of carbenoxolone (Licorice) on anthropometric and metabolic parameters of patients with this polymorphism

RSSDI0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
RSSDI
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients who sign informed consent
  • Type 2 diabetics confirmed by ADA criteria
  • Metabolic syndrome subjects confirmed by IDF criteria
  • Polycystic ovary syndrome subjects confirmed by rotterdam criteria

排除标准

  • Type 1 diabetes
  • Diabetics on insulin
  • Subjects with HbA1C >9.5%, FBS >200 mg/dl,
  • BP >160/100,eGFR >30%
  • Known hypokalemia
  • Women of child bearing potential
  • Currently on alcohol abuse

研究者

发起方
RSSDI

相似试验